Artificial intelligence in next-generation breast cancer detection
advertisement
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More Purchasing Insights

The economics of medical equipment service Insights from the market analysts at MD Buyline

Navigating the molecular imaging market Purchasing insights from the experts at MD Buyline

Clinical engineering and the science of the capital budget process Purchasing insights from the experts at MD Buyline

Purchasing insights for cardiac ultrasound Guidance from the market experts at MD Buyline

Purchasing insights for pediatric imaging Insights from the expert analysts at MD Buyline

See All Purchasing Insights  

Women's Health Homepage

AI solution distinguishes complex pathologies for accurate breast cancer diagnosis Classify ductal carcinoma in situ from atypia

Dense breast laws not boosting ultrasound screening rates: study Researchers suggest risk of overdiagnosis may outweigh benefits in some cases

Three reasons growth in the mammo systems market will likely slow Insights from the market analysts at Signify Research

Radiotherapy beats anti-hormonal therapy for some breast cancer patients, says study Avoiding side effects such as hot flashes, weight gain and bone fracture

NY law requires coverage for medically necessary mammo for women under 40 More than 12,000 younger women diagnosed with breast cancer annually

Insights on implementing digital breast tomosynthesis from someone who knows As a radiologist launching her third DBT program at a breast imaging facility, Dr. Stacy Smith-Foley is uniquely poised to discuss its benefits

AI could enhance efficiency and accuracy of DBT, says study Can help reduce reading times for DBT

Study calls for greater discussion of cost in breast cancer surgery decisions Nearly one in three women consider cost when choosing breast cancer surgery procedures

The significance of the MQSA updates and ACP guidelines Setbacks and milestones for the breast imaging community

Improving care by enhancing fetal ultrasound imaging New tech is supporting better outcomes at NYU Winthrop

Artificial intelligence in next-generation breast cancer detection

From the July 2019 issue of DOTmed HealthCare Business News magazine

By James Laskaris

Breast cancer is the second-most common cancer among women in the United States.
Last year approximately 268,000 new cases of breast cancer were diagnosed in the U.S., and over 40,000 women died of the disease. When breast cancer is found early, the five-year survival rate is 96%. If not identified until more advance stages (e.g., stage 4), the five-year survival rate drops to 16%. The key to survival is early detection.

One area of increased focus is improving technology to increase the accuracy of diagnosing cancer in women with dense breasts. Manufacturers have turned to developing artificial intelligence (AI)-based software for consistency, improved image quality, and detection of lesions in dense tissue. With the added promise of improving workflow, AI is projected to grow to a $2 billion market by 2023.
Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.


Screening is the key to early detection. In 2002, there were 10 million mammography screening procedures performed in the U.S. Now the number has grown to approximately 37 million per year, performed in more than 10,000 certified screening centers in the U.S. This rapid increase is primarily due to a combination of increased payment levels for digital mammography, legislative initiatives, and guidelines that lower the recommended age of screening for certain patients.

The downside of mammography is that it can produce both false positives and negatives. Of the 37 million screening procedures performed each year, 10% of patients will require a follow-up diagnostic screening, ultrasound, or biopsy to rule out cancer. This can add to the cost of the procedure as well as place undue stress on the patient. On the other side, about 20% of mammograms produce false negatives. A missed lesion can lead to a delay in treatment, which can impact the patient prognosis. Patients most at risk are younger women with dense breast tissue.

Using technology to assist physicians in diagnosing breast cancer is not new. CAD systems first entered the market in 1998 (Hologic’s R2 ImageChecker) in a drive to help improve the diagnosis rate for mammography. The technology is based on using image recognition of preprogrammed patterns that indicate possible diseases such as cancer. This had its limitations, resulting in unnecessary follow-up procedures or missed cancers. Artificial intelligence (AI) first appeared in the 1950s in academic settings. In the late 1990s it entered the healthcare and data mining markets. AI has the ability learn new patterns of cancers on its own (unsupervised learning) from what it has experienced over time. Because of this, the effectiveness of AI will continue to improve with use over time.
  Pages: 1 - 2 - 3 >>

Women's Health Homepage


You Must Be Logged In To Post A Comment